I think I've heard Gerald refer to around 800 patients in order to get FDA approval. I'm not sure what he means by a 500 million dollar license deal in the cards? In 3 or 4 years our LymPro revenue could hit 500 million. If you multiply those by 10 you get a 5 Billion market cap from LymPro alone in 3 or 4 years. If someone thinks LymPro is worth 5 Billion in 5 years, what is it worth now? I would think 500 million to 1 billion dollars. How much up front cash will a Big Pharma pay to license LymPro? I don't think 500 million, but I could see 50 to 100 million in up front cash. I don't know what Fibonacci is suggesting.